Nuvectis Pharma Inc. Insider Trading
NVCT
Insiders bought 250K on the open market and sold nothing.
Get an email when NVCT's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30 | Marlio Charles Mosseri Large holder | Bought | 50,000 | $18.32 | 916K | 1.5% | Form 4 |
| Jun 30 | Ron Bentsur Chairman & CEO | Bought | 12,500 | $20.00 | 250K | 0.3% | Form 4 |
| Nov 5, 2025 | Ron Bentsur Chairman & CEO | Bought | 5,000 | $5.72 | 29K | 0.1% | Form 4 |
| Nov 5, 2025 | Juan Sanchez Director | Bought | 13,000 | $5.79 | 75K | 20% | Form 4 |
| Nov 5, 2025 | Matthew L. Kaplan Director | Bought | 11,000 | $5.84 | 64K | 9.7% | Form 4 |
| Oct 23, 2025 – Oct 27, 2025 | Marlio Charles Mosseri Large holder | Bought 3 parts | 154,770 | $6.18 average | 957K | 5.0% | Form 4 |
| Jun 20, 2025 | Marlio Charles Mosseri Large holder | Bought | 5,603 | $7.99 | 45K | 0.2% | Form 4 |
| Jun 17, 2025 – Jun 18, 2025 | Marlio Charles Mosseri Large holder | Bought 2 parts | 33,442 | $8.06 average | 270K | 1.1% | Form 4 |
| May 12, 2025 | Marlio Charles Mosseri Large holder | Bought | 21,167 | $8.11 | 172K | 0.7% | Form 4 |
| May 8, 2025 – May 9, 2025 | Marlio Charles Mosseri Large holder | Bought 6 parts | 27,662 | $8.94 average | 247K | 1.0% | Form 4 |
| Feb 7, 2025 | Marlio Charles Mosseri Large holder | Bought | 240,000 | $5.00 | $1.2M | 9.1% | Form 4 |
| Dec 24, 2024 | Ron Bentsur Chairman & CEO | Bought | 4,500 | $4.65 | 21K | 0.1% | Form 4 |
| Dec 13, 2024 | Marlio Charles Mosseri Large holder | Bought | 17,000 | $4.70 | 80K | 0.7% | Form 4 |
| Dec 12, 2024 – Dec 13, 2024 | Marlio Charles Mosseri Large holder | Bought 2 parts | 49,121 | $4.66 average | 229K | 1.9% | Form 4 |
- Jun 30Marlio Charles MosseriLarge holder · bought 50,000 at $18.32916K1.5% of stake
- Jun 30Ron BentsurChairman & CEO · bought 12,500 at $20.00250K0.3% of stake
- Nov 5, 2025Ron BentsurChairman & CEO · bought 5,000 at $5.7229K0.1% of stake
- Nov 5, 2025Juan SanchezDirector · bought 13,000 at $5.7975K20% of stake
- Nov 5, 2025Matthew L. KaplanDirector · bought 11,000 at $5.8464K9.7% of stake
- Oct 23, 2025 – Oct 27, 2025Marlio Charles MosseriLarge holder · bought 154,770 at avg $6.18957K5.0% of stake
- Jun 20, 2025Marlio Charles MosseriLarge holder · bought 5,603 at $7.9945K0.2% of stake
- Jun 17, 2025 – Jun 18, 2025Marlio Charles MosseriLarge holder · bought 33,442 at avg $8.06270K1.1% of stake
- May 12, 2025Marlio Charles MosseriLarge holder · bought 21,167 at $8.11172K0.7% of stake
- May 8, 2025 – May 9, 2025Marlio Charles MosseriLarge holder · bought 27,662 at avg $8.94247K1.0% of stake
- Feb 7, 2025Marlio Charles MosseriLarge holder · bought 240,000 at $5.00$1.2M9.1% of stake
- Dec 24, 2024Ron BentsurChairman & CEO · bought 4,500 at $4.6521K0.1% of stake
- Dec 13, 2024Marlio Charles MosseriLarge holder · bought 17,000 at $4.7080K0.7% of stake
- Dec 12, 2024 – Dec 13, 2024Marlio Charles MosseriLarge holder · bought 49,121 at avg $4.66229K1.9% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with NVCT
Held by ETFs
NVCT is in 5 US ETFs. The largest of them, with NVCT's weight in each:
Spot a number that looks wrong? Check it in NVCT's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NVCT
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.